JP2009540826A - 軟骨細胞増幅のための無血清培地およびその使用 - Google Patents

軟骨細胞増幅のための無血清培地およびその使用 Download PDF

Info

Publication number
JP2009540826A
JP2009540826A JP2009516524A JP2009516524A JP2009540826A JP 2009540826 A JP2009540826 A JP 2009540826A JP 2009516524 A JP2009516524 A JP 2009516524A JP 2009516524 A JP2009516524 A JP 2009516524A JP 2009540826 A JP2009540826 A JP 2009540826A
Authority
JP
Japan
Prior art keywords
culture medium
medium
chondrocytes
supplemented
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009516524A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009540826A5 (https=
Inventor
スティーブン・デュゲイ
バーバラ・シーモア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of JP2009540826A publication Critical patent/JP2009540826A/ja
Publication of JP2009540826A5 publication Critical patent/JP2009540826A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2306—Interleukin-6 (IL-6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/237—Oncostatin M [OSM]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2009516524A 2006-06-20 2007-06-15 軟骨細胞増幅のための無血清培地およびその使用 Pending JP2009540826A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80530706P 2006-06-20 2006-06-20
PCT/US2007/014075 WO2007149328A1 (en) 2006-06-20 2007-06-15 Serum-free media and their uses for chondrocyte expansion

Publications (2)

Publication Number Publication Date
JP2009540826A true JP2009540826A (ja) 2009-11-26
JP2009540826A5 JP2009540826A5 (https=) 2010-08-05

Family

ID=38626563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009516524A Pending JP2009540826A (ja) 2006-06-20 2007-06-15 軟骨細胞増幅のための無血清培地およびその使用

Country Status (9)

Country Link
US (3) US20070292949A1 (https=)
EP (1) EP2032689A1 (https=)
JP (1) JP2009540826A (https=)
CN (1) CN101490245B (https=)
AU (1) AU2007261530B2 (https=)
BR (1) BRPI0713572A2 (https=)
IL (1) IL196025A (https=)
MX (1) MX2008016429A (https=)
WO (1) WO2007149328A1 (https=)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014030726A1 (ja) * 2012-08-23 2014-02-27 日産化学工業株式会社 タンパク質産生促進剤
JP2014097055A (ja) * 2012-11-13 2014-05-29 Grifols Sa ヒト間葉系幹細胞のための培養培地
JP2014525262A (ja) * 2011-08-31 2014-09-29 セウォン セロンテック カンパニー リミテッド 間葉系幹細胞の基本培養培地の調製方法、間葉系幹細胞の基本培養培地及びこれを利用して培養分化した細胞治療剤
JP2016067312A (ja) * 2014-09-30 2016-05-09 株式会社ジーシー 軟骨分化培養液、及び軟骨組織
WO2016076102A1 (ja) * 2014-11-14 2016-05-19 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
JP2022522230A (ja) * 2019-03-29 2022-04-14 コロン ティシュージーン，インコーポレイテッド 混合細胞遺伝子治療

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889127B2 (en) 2004-07-01 2014-11-18 Icahn School Of Medicine At Mount Sinai Targeted protein replacement for the treatment of lysosomal storage disorders
SI2132562T1 (sl) 2007-04-06 2012-05-31 Genzyme Corp Metode za ovrednotenje celic in celičnih kultur
CN102411484B (zh) * 2010-09-20 2015-01-28 联想(北京)有限公司 一种显示系统中的图像显示方法和装置
LT2753346T (lt) 2011-09-07 2020-08-10 Mount Sinai School Of Medicine Ceramidazė ir ląstelių diferenciacija
ES2897825T3 (es) 2012-06-01 2022-03-02 Icahn School Med Mount Sinai Niveles de ceramida en el tratamiento y prevención de infecciones
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
PT2968479T (pt) 2013-03-14 2019-08-07 Icahn School Med Mount Sinai Composições terapêuticas de ceramidase ácida e métodos de fabrico e utilização
WO2015016357A1 (ja) * 2013-08-01 2015-02-05 株式会社ツーセル 軟骨損傷治療剤及びその製造方法
CN104630138B (zh) * 2013-11-06 2017-11-14 陕西瑞盛生物科技有限公司 一种无血清软骨细胞培养液
CN107849529A (zh) * 2014-12-31 2018-03-27 迈克尔·莫勒 用于人脂肪基质细胞临床生长的细胞培养基的人血清
CN108295243A (zh) * 2018-02-27 2018-07-20 上海中医药大学附属龙华医院 可溶性Jagged1肽在制备促进关节软骨修复的药物中的应用
CN109022356A (zh) * 2018-08-30 2018-12-18 丰泽康生物医药（深圳）有限公司 一种提高间充质干细胞向软骨细胞分化的无血清培养基
CN111019887A (zh) * 2019-11-11 2020-04-17 浙江卫未生物医药科技有限公司 阻止软骨细胞去分化的培育方法
CN113215085B (zh) * 2021-05-07 2024-05-10 澳门大学 一种脂类物质添加剂及其应用
CN113106066B (zh) * 2021-05-13 2022-08-23 杭州艾名医学科技有限公司 一种肉瘤细胞培养基以及采用该培养基体外生产Matrigel原液的方法
US11692167B2 (en) 2021-08-02 2023-07-04 Montana State University Chemically defined serum replacements for cell culture
WO2025117331A1 (en) 2023-12-01 2025-06-05 Eli Lilly And Company Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same
CN118909927B (zh) * 2024-09-12 2025-09-12 上海多宁生物科技股份有限公司 一种高表达的cho细胞培养方法

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000319250A (ja) * 1998-04-03 2000-11-21 Sankyo Co Ltd スルホンアミド誘導体
JP2001089390A (ja) * 1999-09-16 2001-04-03 Sumitomo Pharmaceut Co Ltd 軟骨障害治療剤の新規なスクリーニング方法
JP2001163885A (ja) * 1999-09-29 2001-06-19 Sankyo Co Ltd スルホンアミド誘導体
JP2002284686A (ja) * 2001-03-28 2002-10-03 Sankyo Co Ltd スルホンアミド化合物を含有する医薬組成物
WO2003080806A2 (en) * 2002-03-18 2003-10-02 National Jewish Medical And Research Center Method for production of neutrophils and uses therefor
WO2004092785A2 (en) * 2003-03-31 2004-10-28 Litton Systems, Inc. Bonding method for microchannel plates
JP2004534720A (ja) * 2000-10-16 2004-11-18 ジェネンテック・インコーポレーテッド Ｗｉｓｐポリペプチドを用いる治療方法
JP2005501513A (ja) * 2000-12-08 2005-01-20 ジェネンテック・インコーポレーテッド 軟骨疾患の診断法及び治療法
WO2005018630A1 (en) * 2003-08-11 2005-03-03 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for the treatment of canine ostheoarthritis
JP2005515777A (ja) * 2002-01-25 2005-06-02 ジェンザイム・コーポレーション 軟骨細胞のための無血清培地およびその使用法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
US5202116A (en) * 1989-04-10 1993-04-13 Oncogen Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5843892A (en) * 1989-12-18 1998-12-01 California Institute Of Technology Stimulation of nerve growth and/or vitality
US5188828A (en) * 1990-11-08 1993-02-23 Brigham And Women's Hospital Interleukin-6 to stimulate erythropoietin production
AU2882992A (en) * 1991-11-06 1993-06-07 Arthur A. Axelrad Cell culture medium
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
EP0891419A4 (en) * 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
WO1998004681A2 (en) * 1996-07-25 1998-02-05 Genzyme Corporation Chondrocyte media formulations and culture procedures
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US6156729A (en) * 1997-10-15 2000-12-05 California Institute Of Technology Leukemia inhibitory factor for use in modulating inflammation and pain
CA2348687A1 (en) * 1998-11-09 2000-05-18 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Serum free medium for chondrocyte-like cells
US20030202977A1 (en) * 1998-11-16 2003-10-30 New York University Treatment of osteoarthritis
US6635802B1 (en) * 2000-01-10 2003-10-21 The Texas A&M University System Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
US7005252B1 (en) * 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
JP2007536936A (ja) * 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 幹細胞集団および使用方法
US7615374B2 (en) * 2007-09-25 2009-11-10 Wisconsin Alumni Research Foundation Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000319250A (ja) * 1998-04-03 2000-11-21 Sankyo Co Ltd スルホンアミド誘導体
JP2001089390A (ja) * 1999-09-16 2001-04-03 Sumitomo Pharmaceut Co Ltd 軟骨障害治療剤の新規なスクリーニング方法
JP2001163885A (ja) * 1999-09-29 2001-06-19 Sankyo Co Ltd スルホンアミド誘導体
JP2004534720A (ja) * 2000-10-16 2004-11-18 ジェネンテック・インコーポレーテッド Ｗｉｓｐポリペプチドを用いる治療方法
JP2005501513A (ja) * 2000-12-08 2005-01-20 ジェネンテック・インコーポレーテッド 軟骨疾患の診断法及び治療法
JP2002284686A (ja) * 2001-03-28 2002-10-03 Sankyo Co Ltd スルホンアミド化合物を含有する医薬組成物
JP2005515777A (ja) * 2002-01-25 2005-06-02 ジェンザイム・コーポレーション 軟骨細胞のための無血清培地およびその使用法
WO2003080806A2 (en) * 2002-03-18 2003-10-02 National Jewish Medical And Research Center Method for production of neutrophils and uses therefor
WO2004092785A2 (en) * 2003-03-31 2004-10-28 Litton Systems, Inc. Bonding method for microchannel plates
WO2005018630A1 (en) * 2003-08-11 2005-03-03 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for the treatment of canine ostheoarthritis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6012045869; Ａｒｔｈｒｉｔｉｓ　＆　Ｒｈｅｕｍａｔｉｓｍ Ｖｏｌ．５４，　Ｎｏ．２, 200602, ｐ．５４０-５５０ *

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014525262A (ja) * 2011-08-31 2014-09-29 セウォン セロンテック カンパニー リミテッド 間葉系幹細胞の基本培養培地の調製方法、間葉系幹細胞の基本培養培地及びこれを利用して培養分化した細胞治療剤
US11371013B2 (en) 2012-07-24 2022-06-28 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10590380B2 (en) 2012-07-24 2020-03-17 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
WO2014030726A1 (ja) * 2012-08-23 2014-02-27 日産化学工業株式会社 タンパク質産生促進剤
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
JPWO2014030726A1 (ja) * 2012-08-23 2016-08-08 日産化学工業株式会社 タンパク質産生促進剤
KR101831469B1 (ko) * 2012-11-13 2018-02-22 그리폴스, 에스.에이. 인간 간엽 줄기세포용 배지
JP2014097055A (ja) * 2012-11-13 2014-05-29 Grifols Sa ヒト間葉系幹細胞のための培養培地
JP2016067312A (ja) * 2014-09-30 2016-05-09 株式会社ジーシー 軟骨分化培養液、及び軟骨組織
JPWO2016076102A1 (ja) * 2014-11-14 2017-10-05 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
WO2016076102A1 (ja) * 2014-11-14 2016-05-19 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
EP3536778A1 (en) 2014-11-14 2019-09-11 Regenesis Science Co. Ltd. Method for serum-free culture of chondrocytes and serum-free culture medium
JP2019150057A (ja) * 2014-11-14 2019-09-12 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
JP2020191899A (ja) * 2014-11-14 2020-12-03 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
JP7008360B2 (ja) 2014-11-14 2022-02-10 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
US11427808B2 (en) 2014-11-14 2022-08-30 Regenesis Science Co., Ltd. Method for serum-free culture of chondrocytes and serum-free culture medium
JP2022522230A (ja) * 2019-03-29 2022-04-14 コロン ティシュージーン，インコーポレイテッド 混合細胞遺伝子治療

Also Published As

Publication number Publication date
EP2032689A1 (en) 2009-03-11
US20130273010A1 (en) 2013-10-17
MX2008016429A (es) 2009-03-20
CN101490245A (zh) 2009-07-22
AU2007261530A1 (en) 2007-12-27
AU2007261530B2 (en) 2014-02-06
IL196025A0 (en) 2011-08-01
WO2007149328A1 (en) 2007-12-27
CN101490245B (zh) 2013-01-16
IL196025A (en) 2014-12-31
BRPI0713572A2 (pt) 2012-10-23
US20120213745A1 (en) 2012-08-23
US20070292949A1 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
CN101490245B (zh) 无血清培养基及其在软骨细胞扩增中的用途
US7932084B2 (en) Methods and compositions for growing adipose stem cells
JP2005515777A (ja) 軟骨細胞のための無血清培地およびその使用法
JP6191694B2 (ja) 軟骨損傷治療剤及びその製造方法
WO2021254296A1 (zh) 一种生物活性物质组合物、包含所述组合物的无血清培养基及其用途
JP5524079B2 (ja) 成長因子の組合せを使用する骨髄幹細胞及び間葉系幹細胞の骨形成分化
KR20210044749A (ko) 무혈청 배지 조성물
JPWO2006093172A1 (ja) 成体幹細胞の体外増幅方法
KR20110097064A (ko) 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법
WO2020013090A1 (ja) 神経様細胞の製造方法
JP4469371B2 (ja) 脱分化型軟骨細胞の軟骨細胞への再分化用培地
JP7799153B2 (ja) 間葉系幹細胞の製造方法
AU2014202438A1 (en) Serum-Free Media and Their Uses for Chondrocyte Expansion
WO2021060460A1 (ja) 生体組織損傷の修復剤の製造方法および生体組織損傷の修復剤
KR102218126B1 (ko) 소변 유래 줄기세포의 미분화능을 유지하는 방법
WO2021248675A1 (zh) 一种干细胞向成软骨分化的诱导剂及其应用
JP2003235548A (ja) ヒト細胞の培養用培地および培養方法
WO2024063020A1 (ja) 椎間板治療剤
CN120035655A (zh) 新的牙髓干细胞群
JP2014183784A (ja) ヒト造血幹細胞を増幅させるための組成物及び方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100615

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100615

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20120309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120904

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121203

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130827

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140507